{
 "page": "https://omnirx.org/conditions/ovarian-cancer/niraparib-tosylate",
 "edition": "2026-11",
 "editionRoot": "006ab9a329709cbe",
 "license": "https://omnirx.org/license",
 "generated": "2026-11-11",
 "condition": {
  "id": "ovarian-cancer",
  "name": "Ovarian Cancer"
 },
 "drug": {
  "ingredient": "Niraparib Tosylate",
  "brands": [
   "Zejula"
  ]
 },
 "orderIsRanking": false,
 "orderNote": "Fixed order: the FDA label, public Medicare facts, the manufacturer, charities, research access. It is not a ranking and no saving is computed.",
 "routes": [
  {
   "id": "label",
   "title": "Why this drug and this condition are paired",
   "found": true,
   "quote": "Maintenance Treatment of Recurrent Ovarian Cancer ZEJULA ® is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial re",
   "context": "indication",
   "source": "https://api.fda.gov/drug/label.json?search=set_id:%220fe9d533-67a9-4981-978a-1e84755ae30b%22&limit=1",
   "readOn": "2026-11-10",
   "fact_id": "928fee089b9ee3ec1a112b8e"
  },
  {
   "id": "part-d",
   "title": "Medicare Part D: the yearly out-of-pocket threshold",
   "found": true,
   "text": "$2,400 in 2027 ($2,100 in 2026)",
   "source": "https://www.cms.gov/files/document/2027-announcement.pdf",
   "readOn": "2026-11-08"
  },
  {
   "id": "price",
   "title": "Medicare negotiated price",
   "found": false,
   "usd30DaySupply": null,
   "effective": null,
   "source": null,
   "readOn": null
  },
  {
   "id": "program",
   "title": "Manufacturer and foundation programs",
   "found": true,
   "programs": [
    {
     "name": "GSK Patient Assistance Program (GSK ViiV Healthcare Patient Access Programs Foundation)",
     "url": "https://gskpaf.org/gsk/prescription-medicine-patient-assistance/",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "List of eligible products (GSK prescription medicines)",
     "status": null,
     "statusRead": null,
     "fact_id": "d57754518c1520f943302654"
    }
   ]
  },
  {
   "id": "funds",
   "title": "Charitable funds for Ovarian Cancer",
   "found": true,
   "fundsHeld": 5,
   "open": 4,
   "readOn": "2026-11-08",
   "openFunds": [
    {
     "name": "Ovarian Cancer",
     "org": "CancerCare"
    },
    {
     "name": "Ovarian Cancer - Medicare Access",
     "org": "HealthWell Foundation"
    },
    {
     "name": "Ovarian cancer",
     "org": "TotalAssist (Patient Advocate Foundation copay funds)"
    },
    {
     "name": "Ovarian cancer health equity",
     "org": "TotalAssist (Patient Advocate Foundation copay funds)"
    }
   ],
   "hubUrl": "https://omnirx.org/conditions/ovarian-cancer"
  },
  {
   "id": "trials",
   "title": "Clinical trial access",
   "found": false,
   "recruitingInterventionalTrials": null,
   "source": null,
   "readOn": null,
   "fact_id": null
  }
 ]
}